US BANCORP \DE\ - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$287,011
-6.0%
23,603
-2.9%
0.00%
Q2 2023$305,321
-16.2%
24,309
-26.1%
0.00%
-100.0%
Q1 2023$364,562
-3.9%
32,873
+5.8%
0.00%0.0%
Q4 2022$379,255
-23.8%
31,061
-34.7%
0.00%0.0%
Q3 2022$498,000
-5.9%
47,559
-3.5%
0.00%0.0%
Q2 2022$529,000
+269.9%
49,292
+227.5%
0.00%
Q1 2022$143,000
+14200.0%
15,049
+16809.0%
0.00%
Q4 2021$1,000
-99.0%
89
-99.2%
0.00%
Q3 2021$104,000
-18.1%
10,907
-17.3%
0.00%
Q2 2021$127,000
+14.4%
13,182
+17.4%
0.00%
Q1 2021$111,000
+1485.7%
11,227
+3408.4%
0.00%
Q4 2020$7,000
+133.3%
320
+53.1%
0.00%
Q3 2020$3,0000.0%2090.0%0.00%
Q2 2020$3,000
-25.0%
209
-51.2%
0.00%
Q1 2020$4,000
-33.3%
428
-29.0%
0.00%
Q4 2019$6,000
-90.2%
603
-87.7%
0.00%
Q2 2019$61,000
+38.6%
4,896
+50.9%
0.00%
Q1 2019$44,000
+528.6%
3,245
+365.6%
0.00%
Q4 2018$7,000
-41.7%
697
-14.4%
0.00%
Q1 2018$12,0000.0%814
-0.4%
0.00%
Q4 2017$12,0000.0%817
+0.5%
0.00%
Q3 2017$12,000813
+1013.7%
0.00%
Q4 2016$0
-100.0%
73
-98.5%
0.00%
Q3 2016$36,000
+38.5%
4,8050.0%0.00%
Q2 2016$26,000
-36.6%
4,8050.0%0.00%
Q1 2016$41,000
-12.8%
4,8050.0%0.00%
Q4 2015$47,000
-29.9%
4,8050.0%0.00%
Q3 2015$67,000
-57.1%
4,805
-56.5%
0.00%
-100.0%
Q2 2015$156,000
+24.8%
11,045
-3.6%
0.00%
Q1 2015$125,000
+16.8%
11,455
-10.8%
0.00%
Q4 2014$107,00012,8450.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 22,790,134$182,777,0006.12%
Perceptive Advisors 24,609,700$197,369,0005.32%
SECTORAL ASSET MANAGEMENT INC 3,441,922$27,604,0004.76%
Palo Alto Investors LP 7,162,920$57,447,0003.83%
Avoro Capital Advisors LLC 11,100,000$89,022,0003.71%
SPHERA FUNDS MANAGEMENT LTD. 2,930,320$23,501,0003.63%
Ghost Tree Capital, LLC 1,705,000$13,674,0003.48%
Novo Holdings A/S 2,317,870$18,589,0003.18%
Copernicus Capital Management, LLC 335,000$2,687,0002.50%
Boxer Capital, LLC 2,325,000$18,647,0001.35%
View complete list of AMICUS THERAPEUTICS INC shareholders